Addleshaws and Hogan Lovells take roles on rare pharma IPO
Addleshaw Goddard and Hogan Lovells are among the firms to have advised on the £135m Aim listing of pharmaceutical company Clinigen, a rare UK IPO for the industry. Clinigen, which supplies drugs for clinical tests, has raised £50m from the listing, including a £10 million cash injection which the group is expected to spend on […]